Results
18
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
18 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
COTN | CHF 346.50 | 0.6% | 52.5% | CHF 2.7b | CHF 391.33 | PE153.8x | E48.3% | 0.3% | Tech | ||
SQN | CHF 303.40 | -1.0% | 73.5% | CHF 4.5b | CHF 308.60 | PE17.6x | E13.1% | 1.4% | Diversified Financials | ||
EMMN | CHF 883.00 | -0.3% | -5.5% | CHF 4.7b | CHF 1,000.25 | PE24.5x | E15.3% | 1.8% | Food, Beverage & Tobacco | ||
BARN | CHF 1,376.00 | 0.6% | -10.4% | CHF 7.5b | CHF 1,636.64 | PE26.3x | E25.0% | 2.1% | Food, Beverage & Tobacco | ||
GF | CHF 67.15 | 3.1% | 17.2% | CHF 5.5b | CHF 75.50 | PE26.3x | E23.0% | 1.9% | Capital Goods | ||
CLN | CHF 13.34 | 0.6% | -12.6% | CHF 4.4b | CHF 16.01 | PE37.2x | E30.2% | 3.1% | Materials | ||
SGSN | CHF 94.64 | 0.4% | 17.3% | CHF 17.6b | CHF 92.02 | PE32.2x | E12.3% | 3.4% | Commercial Services | ||
LMN | CHF 19.80 | -0.2% | -15.4% | CHF 211.5m | CHF 25.98 | PE23.5x | E30.0% | 2.8% | Consumer Services | ||
LEHN | CHF 1,250.00 | 1.6% | -37.4% | CHF 1.4b | CHF 1,609.50 | PE28.7x | E18.4% | 4.0% | Tech | ||
SWON | CHF 15.72 | -1.4% | -11.2% | CHF 2.4b | CHF 18.00 | PE155.4x | E52.3% | 2.3% | Tech | ||
DAE | CHF 182.20 | 5.4% | 1.9% | CHF 3.1b | CHF 182.00 | PE42.3x | E23.8% | 1.8% | Capital Goods | ||
SENS | CHF 67.00 | -5.6% | -13.7% | CHF 1.0b | CHF 79.17 | PS4.4x | E104.7% | n/a | Tech | ||
TEMN | CHF 59.10 | 0.2% | -15.3% | CHF 4.3b | CHF 64.27 | PE37.3x | E14.3% | 1.9% | Software | ||
YPSN | CHF 415.00 | 2.2% | 66.0% | CHF 5.7b | CHF 426.20 | PE72.3x | E33.3% | 0.5% | Healthcare | ||
VACN | CHF 437.20 | 0.4% | 23.1% | CHF 13.1b | CHF 485.00 | PE65.5x | E22.5% | 1.4% | Capital Goods | ||
UBXN | CHF 79.90 | 1.3% | 1.8% | CHF 588.6m | CHF 80.00 | PS1.6x | E108.3% | 1.3% | Semiconductors | ||
SKAN | CHF 81.00 | 1.3% | 2.0% | CHF 1.8b | CHF 97.50 | PE56.5x | E20.1% | 0.4% | Pharmaceuticals & Biotech | ||
STMN | CHF 125.45 | -0.8% | -6.3% | CHF 20.0b | CHF 134.83 | PE69.5x | E21.8% | 0.7% | Healthcare |